The Clade I Mpox outbreak has emerged as a significant public health concern, particularly in Central Africa, where over 50,000 suspected mpox cases have been reported since January 2024.With the World Health Organization declaring the situation a Public Health Emergency of International Concern, the urgency for mpox prevention recommendations is at an all-time high.
Tecovirimat-resistant mpox has emerged as a concerning public health issue in the United States, with a recent cluster of cases highlighting the challenges posed by this drug-resistant variant of the monkeypox virus (MPXV).Health authorities have identified that all reported mpox cases in this cluster involved individuals with no documented history of prior tecovirimat treatment, raising alarm over the potential for drug resistance to develop.
Copyright © 2025 | WordPress Theme by MH Themes